Previous Close | 0.1759 |
Open | 0.1826 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's Range | 0.1695 - 0.1826 |
52 Week Range | 0.1200 - 0.5500 |
Volume | |
Avg. Volume | 7,911 |
Market Cap | 86.211M |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1300 |
Earnings Date | Sep 16, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LONDON, Ontario and BOSTON - (NewMediaWire) - October 11, 2024 - Experienced leadership team positions company to advance Cell Pouch(TM) bio-hybrid organ programs. - Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative med...
LONDON Ontario and BOSTON - (NewMediaWire) - October 03, 2024 - Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic...